CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China

SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin …

CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China Read More

Artramedia Expands Its Global Reach With Innovative Tools That Help Storytellers, Filmmakers, and Musicians Build Audiences and Shape Culture Worldwide

Empowering creators with data-driven exposure, licensing, and global audience tools. At Artramedia, we believe that powerful stories don’t need a studio — they need connection. Our enhanced tools ensure every …

Artramedia Expands Its Global Reach With Innovative Tools That Help Storytellers, Filmmakers, and Musicians Build Audiences and Shape Culture Worldwide Read More